¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦41Â÷ KSTH Ãß°èÇмú´ëȸ : 2022-09-30

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦41Â÷ KSTH Ãß°èÇмú´ëȸ : 2022-09-30
±³À°ÀÏÀÚ : 2022-09-30
±³À°Àå¼Ò : ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ 5F ÄÁÆÛ·±½º·ë  
±³À°ÁÖÁ¦ : Á¦41Â÷ KSTH Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ
´ã´çÀÚ : ±èÁø¾Æ
¿¬¶ôó : 02-790-2426  
À̸ÞÀÏ : ksth@thrombo.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, ÀÀ±ÞÀÇÇаúÀÇ»çÇÐ, ¿¹¹æÀÇÇÐ, »ý¸®ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ÀÇ·á»çȸÇÐ, ÀÇ·áÀ±¸®ÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥, ÀÇ·á¹ý, ÀÇ·á°æ¿µ, ±âŸ
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 11 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í ±âŸ:10,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09-30 ÄÁÆÛ·±½º·ëA 10:20~10:30 °³È¸»ç  () 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëA 10:30~11:00 Thrombocytopenia in pregnancy : diagnosis and approach to management  Á¤Çظ²(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëB 10:30~11:00 Is anticoagulation needed for atrial arrhythmias except for atrial fibrillation?  ÇÑ»óÁø(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëA 11:00~11:30 Identifying and Treating of refractory ITP  ½Åµ¿¿±(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëB 11:00~11:30 Management of LV thrombus in various LV dysfunction tings  À§Áø(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëA 11:30~12:00 Vaccine-inducedthrombocytopenia  ÃÖÀºÁö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëB 11:30~12:00 Hemostatic strategies for bleeding after antithrombotics and procedures  ÀÌÀç±æ(¿¬¼¼ÀÇ´ë) 
Åä·Ð 09-30 ÄÁÆÛ·±½º·ëA 12:00~12:30 Panel discussion  ¹æ¼ö¹Ì(¼­¿ïÀÇ´ë) 
Åä·Ð 09-30 ÄÁÆÛ·±½º·ëB 12:00~12:30 Panel discussion  ¹ÎÇʱâ(¿¬¼¼ÀÇ´ë) 
½Ä»ç 09-30 ÄÁÆÛ·±½º·ëC 12:30~13:30 Lunch  () 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëA 13:30~14:00 Recent Update of Pulmonary embolism: 2021 ACCP VTE Partial Update  ±èÀÌÇü(°æÈñÀÇ´ë) 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëB 13:30~14:00 Pharmacogenetics of antiplatelet agents  ¹Ú»óÇõ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëA 14:00~14:30 When & How to apply the ECMO in patients with massive embolism  Á¶¿µÀç(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëB 14:00~14:30 Clopidogrel resistence test and management in neurointervention  ¿ÀÀç»ó(¼øûÇâÀÇ´ë) 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëA 14:30~15:00 Pulmonary embolism Alert System  È²Çå±Ô(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëB 14:30~15:00 Platelet function in myeloproliferative neoplasms  ¾È¾Æ¸®(°¡Å縯ÀÇ´ë) 
È޽Ġ09-30  15:00~15:30 Coffee break  () 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëA 15:30~16:30 Oral Presentation-Research and Practice in Thrombosis and Haemostasis  ±è³²±Ù(Â÷ÀÇ°úÇдë) 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëA 16:30~17:00 How to approach clinical bleedings and Bruises? – Bleeding score assessment  ¾çÀ¯Áø(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëB 16:30~17:00 How do we know about that COVID-19 vaccination can be associated with ASCVD Events or not?  ³ª»óÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëA 17:00~17:30 Genetic screening & testing in coagulation disorder  ±è³²Èñ(µ¿¾ÆÀÇ´ë) 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëB 17:00~17:30 KSTH experience of managing Central Lab of anti-PF4 test for COVID-19 vaccine related TTS Diagnosis  À强¼ö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëA 17:30~18:00 Updates of inhibitor managements in Hemophilia  ÀÌÀçÈñ(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 09-30 ÄÁÆÛ·±½º·ëB 17:30~18:00 COVID-19 mRNA Vaccine related Myo-Pericarditis Korean Experiences  ±è°èÈÆ(Àü³²ÀÇ´ë) 
±âŸ 09-30 ÄÁÆÛ·±½º·ëA 18:00~18:20 ¿ì¼ö¿¬Á¦»ó ¹ßÇ¥ ¹× ½Ã»ó  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦41Â÷ KSTH Ãß°èÇмú´ëȸ : 2022-09-30""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦1ȸ ¿©Àǵµ¼º¸ðº´¿ø ÀÓ»óÀÇÇÐ ½ÉÆ÷Áö¾ö : 2022-09-30
´ÙÀ½±Û ´ëÇÑÁßÀçÇ÷°ü¿Ü°úÇÐȸ The 15th KSVES 2022 Symposium : 2022-10-01
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 45 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 40 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 36 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 40 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 34 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 69 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 22 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 33 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 31 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 39 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 34 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 29 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 32 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 35 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 38 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷